Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doravirine PK after cessation in healthy volunteers
NCT03894124Phase 1Completed
- Sponsor
- Chelsea and Westminster Hospital NHS Foundation Trust
- Start
- Jun 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by Chelsea and Westminster Hospital NHS Foundation Trust. Primary endpoint: Steady State Plasma Concentrations of Doravirine After Drug Intake Cessation. Started Jun 2019; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03894124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03894124.